Top

Published in:

01-11-2008 | Editorial

Eu-estrogenemia, WHI, timing and the “geripause”

Authors: Ralph J. Turner, Irwin J. Kerber

Published in: International Urogynecology Journal | Issue 11/2008

Excerpt

The premature termination of the Women’s Health Initiative (WHI) in 2002 has dominated the debates in health care for menopausal women for the past 6 years. Each new release of the findings in a particular subset of patients has prompted a re-analysis of the basic question—“to take estrogen or not to take estrogen”. Three decades of observational large-cohort studies have been re-evaluated in the light of WHI findings. In his Personal Perspective published in Menopause entitled, “NIH and WHI—time for a mea culpa and steps beyond”, Wulf Utian, the executive director of the North American Menopause Society (NAMS), chastised the investigators for their interpretations of the WHI data [1]. …

Utian WH (2007) NIH and WHI—time for a mea culpa and steps beyond. Menopause 14(6):1056–1059PubMed

Kerber IJ, Turner RJ, Miller VM, Clarkson TB, Harman SM, Brinton EA et al (2005) Eu-estrogenemia. J Appl Physiol 99(6):2471–2472PubMedCrossRef

Clarkson TB (2007) NAMS endowed lecture—estrogen effects on articles vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause 14(3):373–384PubMedCrossRef

Dubal DB, Wise PM (2002) Estrogen and neuroprotection: from clinical observations to molecular mechanisms. Dialogues in Clin Neurosciences 4(2):149–161

Suzuki S, Brown CM, Dela Cruz CD, Yang E, Bridwell DA, Wise PM (2007) Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and anti-inflammatory actions. Proc Natl Acad Sci USA 104(14):6013–6018. doi:10.1073/pnas.0610394104 PubMedCrossRef

Zandi PP, Carlson MC, Plassman BL et al (2002) Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache county study. JAMA 288(17):2123–2129PubMedCrossRef

Hendrix SL, Cochrane BB, Nygaard IE et al (2005) Effects of estrogen with and without progestin on urinary incontinence. JAMA 293(8):935–948PubMedCrossRef

Steinauer JE, Waetjen LE, Vittinghoff E et al (2005) Postmenopausal hormone therapy—does it cause incontinence? Obstet Gynecol 106(5):940–945PubMed

Rizk DEE, Hassan HA, Al-Marzouqi AH, Shafiullah M, Fahim MA (2008) Combined estrogen and ghrelin administration decreases expression of p27^kip1 isomyosin and type I in the striated urethral and anal sphincters and levator ani of old ovariectomized rats. Int Urogynecol J. doi:10.1007/s00192-008-0638-3

10.

Turner RJ (2007) Letter to the Editor. Menopause 14(4):809PubMed

11.

Rizk DEE, Fahim MA (2008) Ageing of the female pelvic floor: towards treatment a la carte of the “geripause”. Int Urogynecol J 19:455–458CrossRef

12.

Hodis HN; ELITE: Early Versus Late Intervention Trial With Estradiol. http://clinicaltrials.gov/show/NCT00114517

13.

Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, et al (2007) 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med. 2007 Oct;13(10):1185–1192. Epub 2007 Sep 16. PMID: 17873880

14.

Turner RJ (2008) Letter to the editor. Menopause 15(2):404PubMedCrossRef

Title: Eu-estrogenemia, WHI, timing and the “geripause”
Authors: Ralph J. Turner
Irwin J. Kerber
Publication date: 01-11-2008
Publisher: Springer-Verlag
Published in: International Urogynecology Journal / Issue 11/2008
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-008-0708-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Eu-estrogenemia, WHI, timing and the “geripause”

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2008

Preferences and concerns for delivery: an antepartum survey

Resiniferatoxin in the treatment of interstitial cystitis: a systematic review

Long-term efficacy of tension-free vaginal tape in the management of stress urinary incontinence in women: efficacy at 5- and 7-year follow-up

Attitudes and perceptions regarding subspecialty training in female pelvic medicine and reconstructive surgery

Anal sphincter defects and anal incontinence symptoms after repair of obstetric anal sphincter lacerations in primiparous women

The uterosacral complex: ligament or neurovascular pathway? Anatomical and histological study of fetuses and adults